Announcement of the resolution by the Company
for the ex-dividend record date of cash dividends.
Date of events
2022/06/28
To which item it meets
paragraph 14
Statement
1.Date of the resolution by the board of directors or shareholders meeting
or decision by the Company:2022/06/28
2.Type of ex-rights or ex-dividend (please enter: "Ex-rights",
"Ex-dividend", or "Ex-rights and dividend"):Ex-dividend
3.Type and monetary amount of dividend distribution:
Cash dividends NT$494,021,395, per share distributed NT$3.5
(NT$3,500 per thousand shares). Furthermore, the cash dividend
shall be calculated to the nearest dollar and the decimal figures
shall be rounded off.The amount rounded off from the current of cash dividend
shall be listed as the Company's other income. In case of any change in
the per-share cash dividend as a result of the fact that repurchase of
the Company's shares, the treasury stock is transferred or deleted,
or carries out a cash capital increase, which further affects the
number of the Company's outstanding shares. The chairman shall be authorized
to adjust the shareholder's cash dividend rate according to the distribution
amount adopted for this proposal and the number of the Company's actual
outstanding shares.
4.Ex-rights (ex-dividend) trading date:2022/07/13
5.Last date before book closure:2022/07/14
6.Book closure starting date:2022/07/15
7.Book closure ending date:2022/07/19
8.Ex-rights (ex-dividend) record date:2022/07/19
9.Any other matters that need to be specified:
The expected distribution date for the cash dividends will be
August 4, 2022.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Excelsior Medical Co. Ltd. published this content on 28 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2022 08:50:09 UTC.
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Companyâs principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.